Lv4
580 积分 2023-05-08 加入
TRPC6 inhibition for the treatment of focal segmental glomerulosclerosis: a randomised, placebo-controlled, phase 2 trial of BI 764198
15天前
已完结
Biomarkers for immunotherapy of hepatocellular carcinoma
22天前
已完结
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study
27天前
已完结
Evolving therapeutic landscape of advanced hepatocellular carcinoma
30天前
已完结
In vitro and in vivo pharmacology of NXT629, a novel and selective PPARα antagonist
1个月前
已完结
Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunities
2个月前
已完结
515LBA (PB-515) LBA Posters: CID-078, a first-in-class oral macrocycle cyclin A/B-RxL inhibitor, demonstrates anti-tumor activity in E2F-driven cancers
2个月前
已完结
The role of fatty acid oxidation in the tumor microenvironment: Implications for cancer progression and therapeutic strategies
2个月前
已完结
The role of fatty acid oxidation in metabolic crosstalk between tumor cells and associated factors in the microenvironment
2个月前
已完结
Top companies and drugs by sales in 2024
2个月前
已完结
皖公网安备34019202002308
